cysteine has been researched along with arsenic trioxide in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baker, DH; Lowry, KR | 1 |
Alet, P; Do, B; Guilley-Gaillot, M; Guyon, F; Poupon, J; Pradeau, D | 1 |
Borghi, M; Castellani, P; Ceccarelli, J; Delfino, L; Ferrini, S; Rubartelli, A; Tosetti, F; Zappia, E | 1 |
Boise, LH; Cai, Y; Croutch, C; Gutman, D; Lee, KP; Matulis, SM; Morales, AA; Yehiayan, L | 1 |
Aram, L; Arbel, N; Geula, S; Shoshan-Barmatz, V | 1 |
Castellani, P; Ciriolo, MR; Delfino, L; Lucibello, M; Rubartelli, A; Venè, R | 1 |
Chan, SM; Feng, W; Huang, M; Li, MX; Majeti, R; Mitchell, BS; Thomas, D | 1 |
Bohle, DS; Conklin, DS; Dahabieh, MS; del Rincon, SV; Garnier, N; Gu, Y; Mann, KK; Miller, WH; Nichol, JN; Redstone, GG; Sun, Y | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for cysteine and arsenic trioxide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for cysteine and arsenic trioxide
Article | Year |
---|---|
On-line reversed-phase liquid chromatography hydride generation emission spectrometry: speciation of arsenic in urine of patients intravenously treated with As2O3.
Topics: Arsenic; Arsenic Trioxide; Arsenicals; Calibration; Chromatography, High Pressure Liquid; Cysteine; Humans; Indicators and Reagents; Injections, Intravenous; Oxides; Reproducibility of Results; Solutions; Spectrophotometry, Atomic | 2000 |
7 other study(ies) available for cysteine and arsenic trioxide
Article | Year |
---|---|
Amelioration of selenium toxicity by arsenicals and cysteine.
Topics: Animal Feed; Animals; Arsenic; Arsenic Trioxide; Arsenicals; Chickens; Cysteine; Liver; Male; Oxides; Poultry Diseases; Selenium; Weight Gain | 1989 |
The redox state of the lung cancer microenvironment depends on the levels of thioredoxin expressed by tumor cells and affects tumor progression and response to prooxidants.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Non-Small-Cell Lung; Cysteine; Disease Progression; Glutathione; HCT116 Cells; Humans; Intramolecular Oxidoreductases; Jurkat Cells; Lung Neoplasms; Macrophage Migration-Inhibitory Factors; Mice; Mice, SCID; Oxidation-Reduction; Oxides; Sulfhydryl Compounds; Thioredoxins | 2008 |
Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Cell Line, Tumor; Cell Survival; Cysteine; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glutathione; Humans; Multiple Myeloma; Oxides | 2009 |
VDAC1 cysteine residues: topology and function in channel activity and apoptosis.
Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Cattle; Cysteine; Electrophoresis, Polyacrylamide Gel; Ethylmaleimide; Fluoresceins; Humans; Hydrogen Peroxide; Immunoblotting; Lipid Bilayers; Mice; Mitochondrial Membranes; Oxides; Rabbits; Rats; RNA, Small Interfering; Sodium Selenite; Structure-Activity Relationship; Voltage-Dependent Anion Channel 1 | 2010 |
The cystine/cysteine cycle and GSH are independent and crucial antioxidant systems in malignant melanoma cells and represent druggable targets.
Topics: Antioxidants; Arsenic Trioxide; Arsenicals; Blotting, Western; Buthionine Sulfoximine; Cell Survival; Cysteine; Cystine; Glutathione; Glycine; HMGB1 Protein; Humans; Immunohistochemistry; Melanoma; Oxidation-Reduction; Oxides; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Tumor Cells, Cultured | 2011 |
Role of cysteine 288 in nucleophosmin cytoplasmic mutations: sensitization to toxicity induced by arsenic trioxide and bortezomib.
Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Cell Nucleolus; Cell Proliferation; Cysteine; Cytosol; Drug Resistance, Neoplasm; Flow Cytometry; Free Radical Scavengers; Humans; Leukemia, Myeloid, Acute; Mutation; Nuclear Proteins; Nucleophosmin; Oxides; Pyrazines; Reactive Oxygen Species; Tryptophan; Tumor Cells, Cultured | 2013 |
The novel arsenical darinaparsin is transported by cystine importing systems.
Topics: Amino Acid Transport System y+; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Biological Transport; Cell Line, Tumor; Cysteine; gamma-Glutamyltransferase; Glutathione; Humans; Oxides; Sulfhydryl Compounds | 2014 |